BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home » Authors » Jim Stommen

Articles by Jim Stommen

The MDD Interview: Damon Canfield, whose firm advises on entry into China

March 12, 2012
By Jim Stommen

The MDD Interview: Canfield reveals complexities of Chinese reimbursement system

March 8, 2012
By Jim Stommen
Damon Canfield is a principal in NPI, a Powell, Ohio-based consultancy that specializes in helping U.S. medical-products firms launch into the Chinese market or establish manufacturing there. NPI has technical offices in Shanghai and Guangzhou, China, as well as Hong Kong.
Read More

Administration’s proposed cuts in U.S. spending on prevention/wellness programs are beyond puzzling

March 5, 2012
By Jim Stommen
By JIM STOMMEN Medical Device Daily Contributing Writer The recent decision by the Obama administration to propose big-time funding cuts for medical prevention and wellness programs is, like many of the decisions that come out of Washington, puzzling to say the least. Done as part of the extension of the payroll tax cut, the prevention/wellness cuts supposedly are the political quid pro quo for the lawmakers agreeing to maintain Medicare payments to physicians at existing levels for the remainder of this year — the so-called “Doc fix.” With a snip-snip here and a snip-snip there, seemingly worthwhile wellness efforts such...
Read More

The MDD Interview: Damon Canfield, whose firm advises on entry into China

March 1, 2012
By Jim Stommen
Damon Canfield is a principal in NPI, a Powell, Ohio-based consultancy that specializes in helping U.S. medical-products firms launch into the Chinese market or establish manufacturing there. NPI has offices in Shanghai and Guangzhou, China, as well as Hong Kong.
Read More

The MDD Interview: Arlen Meyers, MD, heads up physician entrepreneurs group

Feb. 22, 2012
By Jim Stommen
Arlen Meyers, MD, is president and CEO of the Society of Physician Entrepreneurs (SoPE). He also is professor of otolaryngology, dentistry and engineering at the University of Colorado Denver. The founder or co-founder of several companies, he is a consultant to life science, IT and investment firms.
Read More

The MDD Interview: Arlen Meyers, MD, heads up physician entrepreneurs group

Feb. 16, 2012
By Jim Stommen
Arlen Meyers, MD, is president and CEO of the Society of Physician Entrepreneurs (SoPE). He also is professor of otolaryngology, dentistry and engineering at the University of Colorado Denver. The founder or co-founder of several companies, he is a consultant to several life science, IT and investment firms.`
Read More

Medicare’s decision to cover weight-reduction efforts is a good move, but details still matter

Jan. 3, 2012
By Jim Stommen
By JIM STOMMEN Medical Device Daily Contributing Writer   Talk about eating from the public trough: The folks who run Medicare are putting their money where our collective mouths are. The nation’s largest health insurance plan reported awhile back that it will pay for screenings and preventive services aimed at helping recipients battle obesity and its attendant medical ailments. For those who screen positive for obesity, the newly covered benefits include initial weekly counseling for the first month, followed by five months of every-other-week appointments. Presuming weight loss continues, another six months of once-monthly sessions may follow. My initial response...
Read More

Ran Bronstein: Founder of medical simulation firm Simbionixdiscusses growth and change in training sector

Jan. 1, 2012
By Jim Stommen

Changing nature of healthcare is reflected in new push for services to become a retail commodity

Dec. 7, 2011
By Jim Stommen
“Okay, hon. I’m headed over to MammothMart. Need to grab some beer and munchies for the Monday night game, a replacement shower head for the bathroom and maybe that new Michael Connelly book." “I might as well get the oil change and lube done on your SUV while I’m there. And while I’m there, I’ll get that loose pair of glasses tightened at the optical shop. Oh yeah, and I guess I’ll have them check out that stomach pain I’ve been having off and on.” If any of the above seems to border on crossing the line between imagination and...
Read More

A tinkerer at heart, Wilson Greatbatch epitomized what that means to medicine

Oct. 4, 2011
By Jim Stommen
A prolific inventor who died last week in upstate New York at the age of 92, Wilson Greatbatch is credited with more than 325 patents, including coming up with the first practical implantable pacemaker. Besides being memorialized for those breakthroughs, he truly should be viewed as an inveterate tinkerer who as much as any single individual represents the very best of what that term means to medical innovation. While the invention of the...
Read More
Previous 1 2 … 6 7 8 9 10 11 12 13 14 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 7, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • 3D illustration of antibodies

    Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

    BioWorld Science
    Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing